THE IMPACT OF EARLY TREATMENT WITH ADALIMUMAB ON RHEUMATOID FACTOR AND ANTI-CITRULLINATED PEPTIDE ANTIBODY LEVELS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE OPTIMA TRIAL

被引：1
|
作者：
Smolen, J. S. [1 ]
Kavanaugh, A. [2 ]
Aletaha, D. [1 ]
Florentinus, S. [3 ]
Li, Y. [3 ]
Lagunes, I. [3 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
[2] Univ Calif San Diego, San Diego, CA 92103 USA
[3] AbbVie, N Chicago, IL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1311
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0135
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [41] RHEUMATOID FACTOR IS ASSOCIATED WITH MORE PARAMETERS OF THE DISEASE ACTIVITY THAN ANTI-CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Damjanovska, L. K.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 972 - 973
  • [42] Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis
    Mikuls, Ted R.
    Holers, V. Michael
    Parrish, Lezlie
    Kuhn, Kristine A.
    Conn, Doyt L.
    Gilkeson, Gary
    Smith, Edwin A.
    Kamen, Diane L.
    Jonas, Beth L.
    Callahan, Leigh F.
    Alarcon, Graciela S.
    Howard, George
    Moreland, Larry W.
    Bridges, S. Louis, Jr.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : 3057 - 3059
  • [43] Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis
    Serena Bugatti
    Laura Bogliolo
    Barbara Vitolo
    Antonio Manzo
    Carlomaurizio Montecucco
    Roberto Caporali
    Arthritis Research & Therapy, 18
  • [44] Anti-citrullinated peptide antibodies profiling in established rheumatoid arthritis
    Manca, Maria Laura
    Alunno, Alessia
    D'Amato, Claudia
    Bistoni, Onelia
    Puxeddu, Ilaria
    Gerli, Roberto
    Migliorini, Paola
    Pratesi, Federico
    JOINT BONE SPINE, 2018, 85 (04) : 441 - 445
  • [45] Anti-citrullinated peptide antibodies and rheumatoid factor isotypes in the diagnosis of rheumatoid arthritis: an assessment of combined tests
    Infantino, Maria
    Manfredi, Mariangela
    Meacci, Francesca
    Sarzi-Puttini, Piercarlo
    Ricci, Cristian
    Atzeni, Fabiola
    Benucci, Maurizio
    CLINICA CHIMICA ACTA, 2014, 436 : 237 - 242
  • [46] ANTI-CITRULLINATED PROTEIN ANTIBODIES AND RHEUMATOID FACTOR EFFECT ON BONE EROSIONS IN A NORFOLK RHEUMATOID ARTHRITIS COHORT: IS BOTH RHEUMATOID FACTOR AND ANTI-CITRULLINATED PROTEIN ANTIBODY TESTING STILL NECESSARY?
    Fenn, Ricky K.
    Steel, Lauren
    Yates, Max
    Mukhtyar, Chetan
    RHEUMATOLOGY, 2017, 56 : 124 - 124
  • [47] Evaluation of the Value of Anti-Citrullinated α-enolase Peptide 1 Antibody in the Diagnosis of Rheumatoid Arthritis
    Zhou, Jiansuo
    Feng, Limei
    Zhang, Hua
    Wang, Tiancheng
    Cui, Liyan
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2019, 49 (04): : 503 - 506
  • [48] Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis
    Kastbom, A.
    Ljungberg, K. Roos
    Ziegelasch, M.
    Wettero, J.
    Skogh, T.
    Martinsson, K.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 194 (03): : 391 - 399
  • [49] THE MUCOSAL ANTI-CITRULLINATED PEPTIDE ANTIBODY RESPONSE IN PRE-CLINICAL RHEUMATOID ARTHRITIS
    Thurlings, R.
    van der Horst, A.
    Choi, I.
    van Schaardenburg, D.
    Gerlag, D.
    Hamann, D.
    Tak, P. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 850 - 850
  • [50] E valuation the serum level of the 14-3-3. protein antibody compare with the Anti-Citrullinated peptide antibody and rheumatoid factor antibody in rheumatoid arthritis patients
    Ali, Zahraa Qasim
    Alattabi, Alaa Saad
    Hamza, Dhamiaa Maki
    AL-gaber, Murtadha Abdullah Abbood
    Zenki, Firas A.
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2023, 18 (08): : 376 - 382
12345